Kyntra Bio (KYNB) Tax Provisions (2015 - 2026)
Kyntra Bio (KYNB) posted Tax Provisions of -$12.2 million for Q4 2025, down 13108.7% sequentially from -$92000.0 in Q2 2025, and down 607700.0% YoY from N/an in Q4 2024.
Kyntra Bio (KYNB) Tax Provisions (2015 - 2026) Analysis & Trends
Kyntra Bio has reported Tax Provisions for 11 years, with the latest figure at -$12.2 million in Q4 2025.
- Quarterly Tax Provisions fell 607700.0% year-over-year to -$12.2 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$12.2 million (down 4368.61% YoY) and the FY2025 annual result came in at -$12.2 million, down 4450.93% from the prior year.
- Tax Provisions fell to -$12.2 million in Q4 2025 per KYNB's latest filing, from -$92000.0 in the prior quarter.
- Over five years, Tax Provisions peaked at $134000.0 in Q1 2021 and troughed at -$12.2 million in Q4 2025.
- A 5-year average of -$634526.3 and a median of $7000.0 in 2024 frame the typical range for Tax Provisions.
- The sharpest annual moves came in 2022 and 2025: Tax Provisions soared 866.67% in 2022, then tumbled 607700.0% in 2025.
- Over 5 years, Tax Provisions stood at $112000.0 in 2021, then dropped by 3.57% to $108000.0 in 2022, then slumped by 262.04% to -$175000.0 in 2023, then surged by 101.14% to $2000.0 in 2024, then sank by 607700.0% to -$12.2 million in 2025.
- According to Business Quant data, Tax Provisions over the past three periods registered -$12.2 million, -$92000.0, and $2000.0 for Q4 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 13.31 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -90.33 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.90 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Kyntra Bio | 30.42 Mn | 30.42 Mn | 1.47 Mn | -1,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,000.00 |
| Dec 31, 2025 | -12.15 Mn |
| Jun 30, 2025 | -92,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | -281,000.00 |
| Mar 31, 2024 | 7,000.00 |
| Dec 31, 2023 | -175,000.00 |
| Sep 30, 2023 | 84,000.00 |
| Jun 30, 2023 | -235,000.00 |
| Mar 31, 2023 | 74,000.00 |
| Dec 31, 2022 | 108,000.00 |
| Sep 30, 2022 | 114,000.00 |
| Jun 30, 2022 | 23,000.00 |
| Mar 31, 2022 | 113,000.00 |
| Dec 31, 2021 | 112,000.00 |
| Sep 30, 2021 | 106,000.00 |
| Jun 30, 2021 | -3,000.00 |
| Mar 31, 2021 | 134,000.00 |